Several published evidences demonstrated that human solid cancers of non-haematopoietic origin might express MHC II molecules and stimulate tumour antigen-specific CD4+ T cells that display direct cytotoxicity toward tumour cells expressing MHC II (1–3). This evidence concerns the gene CD4 and neoplasm.